Brewin Dolphin Wealth Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $357K | Hold |
4,475
| – | – | 0.04% | 103 |
|
|
2022
Q1 | $471K | Hold |
4,475
| – | – | 0.05% | 100 |
|
|
2021
Q4 | $482K | Sell |
4,475
-525
| -11% | -$56.5K | 0.05% | 98 |
|
|
2021
Q3 | $548K | Hold |
5,000
| – | – | 0.06% | 89 |
|
|
2021
Q2 | $468K | Hold |
5,000
| – | – | 0.06% | 97 |
|
|
2021
Q1 | $460K | Buy |
5,000
+100
| +2% | +$9.2K | 0.07% | 92 |
|
|
2020
Q4 | $358K | Hold |
4,900
| – | – | 0.06% | 92 |
|
|
2020
Q3 | $381K | Sell |
4,900
-800
| -14% | -$62.1K | 0.07% | 90 |
|
|
2020
Q2 | $317K | Hold |
5,700
| – | – | 0.07% | 90 |
|
|
2020
Q1 | $169K | Hold |
5,700
| – | – | 0.09% | 71 |
|
|
2019
Q4 | $206K | Hold |
5,700
| – | – | 0.1% | 74 |
|
|
2019
Q3 | $155K | Hold |
5,700
| – | – | 0.08% | 82 |
|
|
2019
Q2 | $137K | Buy |
+5,700
| New | +$137K | 0.07% | 85 |
|